McKesson Corporation told Kevin Fagan that it would no longer buy pharmaceuticals from secondary sources

On November 11, McKesson Corporation told Kevin Fagan that it would no longer buy pharmaceuticals from secondary sources. “…on a going forward basis, [drugs] will only be purchased directly from the manufacturer or from the manufacturer’s designated sole distributor,” McKesson General Counsel Ivan D. Meyerson wrote to Fagan. With this decision the nation’s three largest pharmaceutical wholesalers have pledged to stop buying brand-name pharmaceuticals from secondary wholesalers, the Wall Street Journal reports.

This entry was posted in dangerous-doses-impact. Bookmark the permalink.